Dongkook Pharmaceutical and Bukwang Pharmaceutical Sign Joint Promotion for Hepatocyte-Protective 'Regaron Suspension'

Proven Effects Including Antioxidant, Anti-Inflammatory, and Hepatocyte Protection

Dongkook Pharmaceutical announced on the 20th that it has signed a joint promotion agreement with Bukwang Pharmaceutical for Regaron Suspension, the only hepatocyte-protective suspension formulation in Korea containing original silymarin.

"Legaron Suspension". Dongkook Pharmaceutical

Regaron Suspension uses the same silymarin as Regaron Capsules as its main ingredient and is characterized by the standardization and application of silibinin, the key active component. As a suspension formulation, it is rapidly absorbed in the body and offers high convenience for administration, making it suitable for elderly patients, those with swallowing difficulties, and patients taking multiple medications. It is also convenient for cases requiring immediate hepatocyte protection. The product is an over-the-counter medicine that can be purchased at pharmacies without a prescription, and its single-use pouch type allows for easy intake without water.

Silymarin is a complex of flavonolignans extracted from milk thistle. It comprehensively protects liver function through various mechanisms. Clinical studies have confirmed several direct mechanisms of action on the liver, including strong antioxidant, anti-inflammatory, and hepatoprotective effects. Based on this evidence, silymarin formulations currently rank first in domestic prescriptions among liver-related pharmaceuticals.

A marketing representative from Dongkook Pharmaceutical stated, "The end of the year is a time when gatherings and company dinners are frequent, which can increase the burden on the liver. Since liver function requires time to recover, I hope people will consistently take care of their liver health with medicines such as Regaron Suspension."

This content was produced with the assistance of AI translation services.